Erhan Berber

615 total citations
10 papers, 309 citations indexed

About

Erhan Berber is a scholar working on Oncology, Rheumatology and Molecular Biology. According to data from OpenAlex, Erhan Berber has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Erhan Berber's work include Rheumatoid Arthritis Research and Therapies (3 papers), Herpesvirus Infections and Treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Erhan Berber is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Herpesvirus Infections and Treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Erhan Berber collaborates with scholars based in United States, Switzerland and Germany. Erhan Berber's co-authors include Daniel E. Furst, Andrea Rubbert‐Roth, Christof Schaefer, Evelin Beck, Monika Østensen, Carina Gøtestam Skorpen, Maria Hoeltzenbein, John W. Gnann, Kamal Bharucha and Stephen K. Tyring and has published in prestigious journals such as Neurology, Pain and Annals of the Rheumatic Diseases.

In The Last Decade

Erhan Berber

10 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erhan Berber United States 5 92 73 69 62 40 10 309
María Martínez‐Urbistondo Spain 10 36 0.4× 39 0.5× 19 0.3× 62 1.0× 9 0.2× 27 193
Ariadna Anunciación-Llunell Spain 5 60 0.7× 22 0.3× 17 0.2× 68 1.1× 41 1.0× 11 279
Corina Cianga Romania 10 116 1.3× 55 0.8× 11 0.2× 23 0.4× 19 0.5× 34 323
Ünsal Özgen Türkiye 11 25 0.3× 43 0.6× 32 0.5× 30 0.5× 48 1.2× 32 282
Akshay Batra United Kingdom 14 83 0.9× 139 1.9× 44 0.6× 13 0.2× 32 0.8× 46 531
Elisa Gabanti Italy 12 65 0.7× 171 2.3× 13 0.2× 33 0.5× 14 0.3× 23 372
Elizabeth Wallin United Kingdom 8 166 1.8× 44 0.6× 19 0.3× 32 0.5× 16 0.4× 13 355
Noriko Ammerman United States 13 140 1.5× 41 0.6× 46 0.7× 8 0.1× 32 0.8× 22 466
Fatih Erbey Türkiye 10 27 0.3× 60 0.8× 59 0.9× 26 0.4× 76 1.9× 42 338
F. J. Bemelman Netherlands 10 130 1.4× 120 1.6× 15 0.2× 12 0.2× 19 0.5× 22 327

Countries citing papers authored by Erhan Berber

Since Specialization
Citations

This map shows the geographic impact of Erhan Berber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erhan Berber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erhan Berber more than expected).

Fields of papers citing papers by Erhan Berber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erhan Berber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erhan Berber. The network helps show where Erhan Berber may publish in the future.

Co-authorship network of co-authors of Erhan Berber

This figure shows the co-authorship network connecting the top 25 collaborators of Erhan Berber. A scholar is included among the top collaborators of Erhan Berber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erhan Berber. Erhan Berber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Luigetti, Marco, Alejandra González‐Duarte, Elizabeth A. Mauricio, et al.. (2021). Global open-label extension: 24-month data of patisiran in patients with HATTR amyloidosis. Journal of the Neurological Sciences. 429. 117766–117766. 1 indexed citations
2.
Marques, Wilson, David Adams, Alejandra González‐Duarte, et al.. (2021). Global open-label extension: 24-month data of patisiran in patients with hattr amyloidosis. 245–245. 1 indexed citations
3.
Polydefkis, Michael, Alejandra González‐Duarte, Teresa Coelho, et al.. (2020). Long-term Safety and Efficacy of Patisiran in Patients with hATTR Amyloidosis: Global OLE Study (730). Neurology. 94(15_supplement). 2 indexed citations
4.
Rubbert‐Roth, Andrea, et al.. (2018). A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases. Rheumatology and Therapy. 5(1). 21–42. 98 indexed citations
5.
Mohan, Shalini, et al.. (2017). OP0105 Long-term safety of tocilizumab from large clinical trial and postmarketing populations. Annals of the Rheumatic Diseases. 76. 95–95. 3 indexed citations
6.
Gale, Sara, et al.. (2017). FRI0248 Incidence of melanoma in patients with rheumatoid arthritis treated with tocilizumab. Annals of the Rheumatic Diseases. 76. 579–579. 1 indexed citations
7.
Hoeltzenbein, Maria, Evelin Beck, Carina Gøtestam Skorpen, et al.. (2016). Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data. Seminars in Arthritis and Rheumatism. 46(2). 238–245. 104 indexed citations
8.
Monemi, Sharareh, Erhan Berber, Khaled Sarsour, et al.. (2016). Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources. Rheumatology and Therapy. 3(2). 337–352. 30 indexed citations
9.
Dworkin, Robert H., Richard L. Barbano, Stephen K. Tyring, et al.. (2009). A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain. 142(3). 209–217. 54 indexed citations
10.
Bartlett, Brenda L., Stephen K. Tyring, Kenneth H. Fife, et al.. (2008). Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: The RELIEF trial. Journal of Clinical Virology. 43(2). 190–195. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Martínez‐Urbistondo Breakdown of academic impact, for papers by Ariadna Anunciación-Llunell Breakdown of academic impact, for papers by Corina Cianga Breakdown of academic impact, for papers by Ünsal Özgen Breakdown of academic impact, for papers by Akshay Batra Breakdown of academic impact, for papers by Elisa Gabanti Breakdown of academic impact, for papers by Elizabeth Wallin Breakdown of academic impact, for papers by Noriko Ammerman Breakdown of academic impact, for papers by Fatih Erbey Breakdown of academic impact, for papers by F. J. Bemelman
Rankless by CCL
2026